In the last week, the Biotech industry is up 2.3%, with AbbVie up 3.4%. This means that the industry has gained 6.8% over the past year. Looking forward, earnings are forecast to grow by 25% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 12 Jun 2024 | US$1.2t | US$164.5b | -US$26,797,092,425.07 | 28.1x | -43.3x | 7.1x |
Fri, 10 May 2024 | US$1.1t | US$164.8b | -US$26,733,495,747.45 | 23.2x | -41.9x | 6.8x |
Sun, 07 Apr 2024 | US$1.1t | US$164.4b | -US$23,431,530,428.03 | 21.3x | -48.2x | 6.9x |
Tue, 05 Mar 2024 | US$1.2t | US$167.9b | -US$21,298,840,556.03 | 15.9x | -56x | 7.1x |
Thu, 01 Feb 2024 | US$1.4t | US$204.7b | -US$22,672,999,235.00 | 17.8x | -63.6x | 7x |
Sat, 30 Dec 2023 | US$1.4t | US$204.9b | -US$22,199,644,413.00 | 19.8x | -62.9x | 6.8x |
Mon, 27 Nov 2023 | US$1.2t | US$204.8b | -US$22,013,452,568.00 | 18.6x | -55.7x | 6x |
Wed, 25 Oct 2023 | US$1.2t | US$207.5b | -US$13,040,888,319.00 | 16.2x | -93x | 5.8x |
Fri, 22 Sep 2023 | US$1.3t | US$207.5b | -US$12,875,537,971.00 | 17.1x | -98.4x | 6.1x |
Sun, 20 Aug 2023 | US$1.3t | US$207.6b | -US$12,372,676,716.00 | 17.6x | -102.2x | 6.1x |
Tue, 18 Jul 2023 | US$1.1t | US$186.7b | -US$15,958,556,257.00 | 12.9x | -71.1x | 6.1x |
Thu, 15 Jun 2023 | US$1.2t | US$186.1b | -US$15,929,018,280.00 | 11.7x | -72.3x | 6.2x |
Sat, 13 May 2023 | US$1.2t | US$191.7b | -US$12,347,110,804.00 | 13.8x | -93.5x | 6x |
Mon, 10 Apr 2023 | US$1.2t | US$198.3b | -US$3,291,225,770.00 | 14x | -353.5x | 5.9x |
Wed, 08 Mar 2023 | US$1.1t | US$198.7b | -US$5,119,400,088.00 | 15.9x | -221.2x | 5.7x |
Fri, 03 Feb 2023 | US$1.2t | US$203.9b | US$1.8b | 14.9x | 642.4x | 5.7x |
Sun, 01 Jan 2023 | US$1.1t | US$203.5b | US$1.7b | 14.3x | 663.5x | 5.6x |
Tue, 29 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.7x | 841.8x | 5.5x |
Thu, 27 Oct 2022 | US$1.1t | US$206.5b | US$6.4b | 14.1x | 171.7x | 5.3x |
Sat, 24 Sep 2022 | US$1.0t | US$206.0b | US$5.6b | 13.9x | 182.3x | 4.9x |
Mon, 22 Aug 2022 | US$1.1t | US$206.4b | US$7.3b | 16x | 147.7x | 5.2x |
Wed, 20 Jul 2022 | US$1.1t | US$211.3b | US$10.6b | 17.2x | 102.8x | 5.2x |
Fri, 17 Jun 2022 | US$922.8b | US$212.3b | US$11.0b | 14.6x | 84x | 4.3x |
Sun, 15 May 2022 | US$993.9b | US$212.0b | US$10.6b | 15.6x | 94.1x | 4.7x |
Tue, 12 Apr 2022 | US$1.3t | US$226.8b | US$14.3b | 18.3x | 89.9x | 5.7x |
Thu, 10 Mar 2022 | US$1.2t | US$222.2b | US$10.7b | 19x | 114.4x | 5.5x |
Sat, 05 Feb 2022 | US$1.3t | US$216.1b | US$6.6b | 21.5x | 190.2x | 5.8x |
Mon, 03 Jan 2022 | US$1.4t | US$212.1b | US$2.8b | 25.5x | 509.6x | 6.7x |
Wed, 01 Dec 2021 | US$1.5t | US$211.9b | US$3.1b | 24.4x | 464.8x | 6.9x |
Fri, 29 Oct 2021 | US$1.5t | US$195.8b | -US$3,115,067,500.00 | 24.5x | -474.5x | 7.5x |
Sun, 26 Sep 2021 | US$1.6t | US$196.4b | -US$2,419,608,414.00 | 24.9x | -653.6x | 8.1x |
Tue, 24 Aug 2021 | US$1.6t | US$197.0b | -US$1,662,914,785.58 | 22.2x | -952.7x | 8x |
Wed, 30 Jun 2021 | US$1.5t | US$196.9b | -US$825,939,314.84 | 25.2x | -1810.8x | 7.6x |
-1810.8x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.24% | |
Healthcare | 1.17% | |
Biotech | 2.33% | |
Biotech | 2.33% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$167.70 | 3.4% +US$9.8b | 21.2% | PE49.8x | |
REGN Regeneron Pharmaceuticals | US$1.01k | 1.7% +US$1.9b | 31.7% | PE28.3x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
VRTX Vertex Pharmaceuticals | US$481.53 | 1.4% +US$1.7b | 40.8% | PE30.9x | |
MRNA Moderna | US$148.39 | 2.1% +US$1.2b | 15.9% | PS11x |